|
WO2000073480A1
(en)
*
|
1999-05-27 |
2000-12-07 |
Genovo, Incorporated |
Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus
|
|
US6793926B1
(en)
|
1999-05-27 |
2004-09-21 |
Genovo, Inc. |
Methods for production of a recombinant adeno-associated virus
|
|
WO2000073424A1
(en)
*
|
1999-05-28 |
2000-12-07 |
Mount Sinai School Of Medicine |
A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
|
|
GB9919409D0
(en)
|
1999-08-18 |
1999-10-20 |
Univ Oxford Brookes |
Baculovirus expression system
|
|
WO2004020605A2
(en)
|
2002-08-29 |
2004-03-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circular nucleic acid vectors, and methods for making and using the same
|
|
GB0702694D0
(en)
*
|
2007-02-12 |
2007-03-21 |
Ark Therapeutics Ltd |
Vectors
|
|
GB0702695D0
(en)
*
|
2007-02-12 |
2007-03-21 |
Ark Therapeutics Ltd |
Production of vectors
|
|
EP2019143A1
(en)
|
2007-07-23 |
2009-01-28 |
Genethon |
CNS gene delivery using peripheral administration of AAV vectors
|
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
|
WO2009110001A1
(en)
*
|
2008-03-05 |
2009-09-11 |
Council Of Scientific & Industrial Research |
A polymeric hybrid membrane
|
|
EP2287323A1
(en)
|
2009-07-31 |
2011-02-23 |
Association Institut de Myologie |
Widespread gene delivery to the retina using systemic administration of AAV vectors
|
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
|
CN102884196B
(zh)
*
|
2010-04-01 |
2015-05-06 |
肖卫东 |
重组病毒载体的结构及其制备
|
|
JP2013523175A
(ja)
|
2010-04-14 |
2013-06-17 |
イーエムディー・ミリポア・コーポレーション |
高力価、高純度のウイルスストックの作製方法及びその使用方法
|
|
WO2013170078A1
(en)
|
2012-05-09 |
2013-11-14 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
TWI702955B
(zh)
|
2012-05-15 |
2020-09-01 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒（ａａｖ）ｓｆｌｔ-１治療老年性黃斑部退化（ａｍｄ）
|
|
WO2013190059A1
(en)
|
2012-06-21 |
2013-12-27 |
Association Institut De Myologie |
Widespread gene delivery of gene therapy vectors
|
|
WO2015031686A1
(en)
|
2013-08-30 |
2015-03-05 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
|
ES3042252T3
(en)
|
2014-03-17 |
2025-11-19 |
Adverum Biotechnologies Inc |
Compositions and methods for enhanced gene expression in cone cells
|
|
CN114480502A
(zh)
|
2015-03-02 |
2022-05-13 |
阿德夫拉姆生物技术股份有限公司 |
用于将多核苷酸玻璃体内递送到视网膜视锥的组合物和方法
|
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
|
AU2018373279B2
(en)
|
2017-11-27 |
2024-07-25 |
Trames Bio, Inc. |
Compositions and methods for neurological diseases
|
|
US20190256867A1
(en)
|
2018-02-01 |
2019-08-22 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
|
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
|
CN112041437A
(zh)
|
2018-02-19 |
2020-12-04 |
同源药物公司 |
用于恢复f8基因功能的腺相关病毒组合物和其使用方法
|
|
CN112074605B
(zh)
|
2018-05-08 |
2024-11-22 |
纽洛可科学有限公司 |
抗fam19a5抗体的腺相关病毒（aav）递送
|
|
KR20210130158A
(ko)
|
2019-01-31 |
2021-10-29 |
오레곤 헬스 앤드 사이언스 유니버시티 |
Aav 캡시드의 전사 의존적 유도 진화를 사용하는 방법
|
|
CA3151920A1
(en)
|
2019-08-21 |
2021-02-25 |
Coda Biotherapeutics, Inc. |
Compositions and methods for neurological diseases
|
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
|
|
GB202013940D0
(en)
|
2020-09-04 |
2020-10-21 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
JP2023545731A
(ja)
|
2020-10-07 |
2023-10-31 |
アスクレピオス バイオファーマシューティカル， インコーポレイテッド |
肢帯型２ｉ（ｌｇｍｄ２ｉ）を含むジストログリカノパチー障害を処置するためのフクチン関連タンパク質（ｆｋｒｐ）の治療的アデノ随伴ウイルス送達
|
|
AU2023260822A1
(en)
|
2022-04-29 |
2024-11-14 |
Broadwing Bio Llc |
Complement factor h related 4-specific antibodies and uses thereof
|
|
AU2023260823A1
(en)
|
2022-04-29 |
2024-11-14 |
Broadwing Bio Llc |
Bispecific antibodies and methods of treating ocular disease
|
|
EP4514470A1
(en)
|
2022-04-29 |
2025-03-05 |
Broadwing Bio LLC |
Angiopoietin-related protein 7-specific antibodies and uses thereof
|
|
WO2024227154A1
(en)
|
2023-04-28 |
2024-10-31 |
Broadwing Bio Llc |
Complement component 3 (c3)-specific antibodies and uses thereof
|
|
WO2025040613A1
(en)
*
|
2023-08-21 |
2025-02-27 |
Vector Biopharma Ag |
Cell line for production of helper-dependent adenoviruses
|